Published in Drug Law Weekly, August 12th, 2008
"In this study we examined the vulnerability of KCC2-containing neurons as well as the changes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.